30
Participants
Start Date
December 31, 2014
Primary Completion Date
September 30, 2016
Study Completion Date
September 30, 2016
PDE9i
oral dose, every 12 hours for 28 days
PDE9i
oral dose, every 12 hours for 28 days
placebo for PDE9i
oral dose, every 12 hours for 28 days
PDE9i
oral dose, every 12 hours for 28 days
Interfaith Medical Center, Brooklyn
Interfaith Medical Center, Brooklyn
Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan
Investigational Drug Services, Richmond
Virginia Commonwealth University, Richmond
UNC Hospitals' Investigational Drug Service Pharmacy, Chapel Hill
UNC School of Medicine Clinical and Translational Research Center, Chapel Hill
University of Illinois at Chicago Clinical Research Center, Chicago
University of Illinois Hospital and Health Sciences System, Chicago
A.O.O.R Villa Sofia - V. Cervello, Palermo
University of Illinois Hospital and Health Sciences System, Chicago
Boston Medical Center E7E, Boston
Boston Medical Center, Boston
Boston University Medical Center, Boston
Pfizer Clinical Research Unit, Brussels
Centre for Human Drug Research, Leiden
Royal Liverpool and Broadgreen University Hospital Trust, Liverpool
Guy's and St Thomas' NHS Foundation Trust, London
King's College Hospital NHS Foundation Trust, London
Imperial College Healthcare NHS Trust, London
Central Manchester University Hospitals NHS Foundation Trust, Manchester
Manchester Royal Infirmary, Manchester
Oxford University Hospitals NHS Trust, Oxford
Lead Sponsor
Pfizer
INDUSTRY